Skip to main content

Efficacy and Safety of Empagliflozine and Semaglutide (Once Weekly) in T2DM Patients in Shtip Cover

.blurhash-client-img { display: none !important; }

Efficacy and Safety of Empagliflozine and Semaglutide (Once Weekly) in T2DM Patients in Shtip

Volume 44 (2023): Issue 1 (March 2023)

By: Valentina Velkoska Nakova, Zoran Nakov, Stojka Dokuzova, Tatjana Prosheva and Brankica Krstevska

Open Access

|Mar 2023

Articles in this issue

DOI: https://doi.org/10.2478/prilozi-2023-0008 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345

Journal RSS Feed

Language: English

Page range: 71 - 77

Published on: Mar 29, 2023

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 3 issues per year

Keywords:

once weekly semaglutide,

glycosylated hemoglobin,

hospitalization

Related subjects:

Basic medical science,

History and ethics of medicine,

Clinical medicine,

Clinical medicine, other,

Social sciences,

Education, other

© 2023 Valentina Velkoska Nakova, Zoran Nakov, Stojka Dokuzova, Tatjana Prosheva, Brankica Krstevska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 44 (2023): Issue 1 (March 2023)

Previous article